This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignee: The University of British Columbia. Active years: 2019-2025.
Company Filing History:
Years Active: 2019-2025
Title: Michael Andrew Vaninsberghe: Innovator in Lymphocyte Receptor Research
Introduction
Michael Andrew Vaninsberghe is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of immunology, particularly in the study of lymphocyte receptor chains. With a total of 3 patents to his name, Vaninsberghe is recognized for his innovative approaches to understanding immune responses.
Latest Patents
One of his latest patents focuses on "Methods for determining lymphocyte receptor chain pairs." This patent provides high-throughput sequencing methods to study the diversity and functionality of lymphocyte receptor chains and their pairing. The methods are designed to identify one or more lymphocyte receptor chain pairs in a sample, ensuring confidence in the identification of functional chain pairs.
Career Highlights
Vaninsberghe is affiliated with the University of British Columbia, where he continues to advance research in his field. His work has implications for understanding immune system functions and developing therapeutic strategies.
Collaborations
He collaborates with esteemed colleagues, including Carl Lars Genghis Hansen and Georgia Elizabeth Mewis. Their combined expertise enhances the research output and innovation in their projects.
Conclusion
Michael Andrew Vaninsberghe is a prominent figure in the realm of lymphocyte receptor research, contributing valuable insights and methodologies through his patents. His work at the University of British Columbia and collaborations with fellow researchers underscore his commitment to advancing scientific knowledge.